BSE filing, NSE: KIRLOSBROS. Summary written from the filing by ALFA Finder's alert engine.
Kirloskar Brothers Ltd: key numbers
- Share price
- ₹1,601.10
- Market cap
- ₹12,714 Cr
- Revenue (annual)
- ₹4,538 Cr
- Net profit (annual)
- ₹373.6 Cr
- P/E (TTM)
- 33.8×Sector 52.2×
- Promoter holding
- 65.95%+0.00% QoQ
- FII holding
- 6.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kirloskar Brothers Ltd
All →Kirloskar Brothers Earnings Call Transcript: Key Takeaways
Kirloskar Brothers reported strong revenue and order intake, but faced margin contraction in its international business due to unfavorable sales mix and higher input costs.
- Call
- Guides 10% growth
Kirloskar Brothers Results Update
Kirloskar Brothers' Q2FY27 consolidated revenue rose 24% YoY and EBITDA 16%. The investor release precedes an analyst call on October 28, 2026.
Kirloskar Brothers Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs 12,767 Mn (+24%), EBITDA Rs 1,432 Mn (11.2% margin), PAT Rs 747 Mn (+4%). H1 revenue Rs 23,816 Mn (+19%). Strategy centres on value-added products and reduced EPC exposure.
Kirloskar Brothers Legal & Regulatory
Kirloskar Brothers paid an exchange penalty of Rs 87,320 for Nomination and Remuneration Committee non-compliance. The board noted the fine at its October 27, 2026 meeting.
- Value
- ₹0.01 Cr
Kirloskar Brothers Q2 FY27 Results: Net Profit ₹74.7 Cr, Up 3.5% YoY
Kirloskar Brothers Ltd reported revenue from operations of ₹1,277 Cr (+24.2% YoY) and net profit of ₹74.7 Cr (+3.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.7 Cr · +3.5% YoY
Kirloskar Brothers Board Meeting Date
Kirloskar Brothers Limited has scheduled a board meeting for October 27, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Other management change announcements
All →Integrated Proteins Management Change
Integrated Proteins appointed Ms. Arushi Aggarwal as Company Secretary and Compliance Officer, effective 29 October 2026. The appointment was approved at a board meeting as a Key Managerial Personnel change.
Suraj Management Change
Suraj Limited appointed Mr. Mayank Balvantbhai Rami as Company Secretary and Compliance Officer effective November 1, 2026. The board approved this KMP appointment on October 29, 2026.
Superior Finlease Management Change
Superior Finlease disclosed that Mr. Krishan Gopal Sharma resigned as CFO and KMP effective 28 Oct 2026 due to personal commitments. No successor is named yet.
Vertex Securities Management Change
Vertex Securities appointed Ms. Unni as Independent Director and Mr. Iyer as CFO, effective October 2026. Both roles were approved at the 28 October board meeting.
iStreet Network Management Change
iStreet Network Ltd announced the resignation of Non-Executive Non-Independent Director Mr. Yash Maheshwari effective 13 October 2026. No financial impact is indicated.
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.